325 related items for PubMed ID: 30497684
1. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
[Abstract] [Full Text] [Related]
2. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
3. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
4. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
Kidney Int; 2024 May; 105(5):1113-1123. PubMed ID: 38360110
[Abstract] [Full Text] [Related]
5. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
Sharma S, Kalra S, Shukla S, Sharma P.
Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
[Abstract] [Full Text] [Related]
6. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
7. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
8. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
[Abstract] [Full Text] [Related]
9. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 30; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
10. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May 30; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
11. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
[Abstract] [Full Text] [Related]
12. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U, Weber LT.
Pediatr Nephrol; 2018 Dec 23; 33(12):2253-2265. PubMed ID: 29750317
[Abstract] [Full Text] [Related]
13. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan 23; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
14. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY, Ji LN, Chen CY, Tu J, Li HR, Bao R, Lin Y.
Zhonghua Er Ke Za Zhi; 2018 Sep 02; 56(9):651-656. PubMed ID: 30180402
[Abstract] [Full Text] [Related]
15. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 02; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
16. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
Kiruba Samuel EM, Krishnamurthy S, Bhanudeep S, Muske S.
Indian Pediatr; 2017 Oct 15; 54(10):831-834. PubMed ID: 28699616
[Abstract] [Full Text] [Related]
17. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Pravitsitthikul N, Willis NS, Hodson EM, Craig JC.
Cochrane Database Syst Rev; 2013 Oct 29; (10):CD002290. PubMed ID: 24166716
[Abstract] [Full Text] [Related]
18. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S.
Indian Pediatr; 2014 May 29; 51(5):371-3. PubMed ID: 24953577
[Abstract] [Full Text] [Related]
19. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
Moorani KN, Hotchandani HM, Zubair AM, Lohana NC, Veerwani NR.
BMC Nephrol; 2019 Jul 03; 20(1):239. PubMed ID: 31269922
[Abstract] [Full Text] [Related]
20. Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome.
Gellermann J, Weber L, Pape L, Tönshoff B, Hoyer P, Querfeld U, Gesellschaft für Pädiatrische Nephrologie (GPN).
J Am Soc Nephrol; 2013 Oct 03; 24(10):1689-97. PubMed ID: 23813218
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
